Full data view for gene MYL2

Information The variants shown are described using the NM_000432.3 transcript reference sequence.

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Type     

DNA change (genomic) (hg19)     

Reference     

DB-ID     

Frequency     

Variant remarks     

ClassClinical     

Template     

Technique     

Disease     

Reference     

Remarks     

Gender     

Age     

α-thal genotype     

β-thal genotype     

Panel size     

Owner     
./. 02 c.54C>A - p.Phe18Leu Unknown BL21 expression host cells; Sf9 cells - GenBank MYL2_00005 - (The article doesn't mention if it's c.54C>A or c.54C>G.) Associated with a typical form of hypertrophic cardiomyopathy, which causes increased left ventricular wall thickness and abnormal electrocardiograph find- ings with no mid-cavity obliteration; decreased the Ca2+ binding affinity ~3-fold compared with HCRLC-WT. No effect of phosphorylation on Ca2+ binding to F18L was observed. - - - - - - - - - - - -
./. 02 c.54C>A - p.Phe18Leu Unknown Blood - GenBank MYL2_00005 - MYL2 mutations are predicted to alter the phosphorylation site and the Ca2+ binding properties. Distribution of the disease genes of the full 197 case series was as follows: MYBPC3, 26%; MYH7, 25%; TNNT2, 4%; TNNI3, 4%; MYL2, 2.5%; and MYL<0.5%. - - - - - - - - - - - -
Legend   How to query